Chengwei Shao

Chengwei Shao

Auto-generated profile, based on publicly available information

Chengwei Shao

Department of Radiology, Changhai Hospital, Shanghai, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Radiology
Verified
Journal Article
Closed access
YBYun Bian
Yun Bian
ZZZhilin Zheng
Zhilin Zheng
XFXu Fang
Xu Fang
HJHui Jiang
Hui Jiang
MZMengmeng Zhu
Mengmeng Zhu
CSChengwei Shao
Chengwei Shao
An artificial intelligence model outperformed radiologists and clinical and radiomics models for prediction of lymph node metastasis at CT in patients with pancreatic ductal adenocarcinoma. Background Although deep learning has brought revolutionary changes in health care, reliance on manually selected cross-sectional images and segmentation remain methodological barriers. Purpose To ...

20 August 2025 in Nature Medicine
Verified
Journal Article
Open access
PDF file
YHYujian Hu
Yujian Hu
YXYilang Xiang
Yilang Xiang
YZYan-Jie Zhou
Yan-Jie Zhou
YHYangyan He
Yangyan He
DLDehai Lang
Dehai Lang
HZHongkun Zhang
Hongkun Zhang
The accurate and timely diagnosis of acute aortic syndrome (AAS) in patients presenting with acute chest pain remains a clinical challenge. Aortic computed tomography (CT) angiography is the imaging protocol of choice in patients with suspected AAS. However, due to economic and workflow constraints in China, the majority of suspected patients initially undergo noncontrast CT as the initial imaging testing, and CT angiography is reserved for those at higher risk. Although noncontrast CT can reveal specific signs indicative of AAS, its diagnostic efficacy when used alone has not been well characterized. Here we present an artificial intelligence-based warning system, iAorta, using noncontrast CT for AAS identification in China, which demonstrates remarkably high accuracy and provides clinicians with interpretable warnings. iAorta was evaluated through a comprehensive step-wise study. In the multicenter retrospective study (n = 20,750), iAorta achieved a mean area under the receiver operating curve of 0.958 (95% confidence interval 0.950–0.967). In the large-scale real-world study (n = 137,525), iAorta demonstrated consistently high performance across various noncontrast CT protocols, achieving a sensitivity of 0.913–0.942 and a specificity of 0.991–0.993. In the prospective comparative study (n = 13,846), iAorta demonstrated the capability to significantly shorten the time to correct diagnostic pathway for patients with initial false suspicion from an average of 219.7 (115–325) min to 61.6 (43–89) min. Furthermore, for the prospective pilot deployment that we conducted, iAorta correctly identified 21 out of 22 patients with AAS among 15,584 consecutive patients presenting with acute chest pain and under noncontrast CT protocol in the emergency department. For these 21 AAS-positive patients, the average time to diagnosis was 102.1 (75–133) min. Finally, iAorta may help prevent delayed or missed diagnoses of AAS in settings where noncontrast CT remains the only feasible initial imaging modality—such as in resource-limited regions or in patients who cannot receive, or did not receive, intravenous contrast.

6 August 2021 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
YBYun Bian
Yun Bian
CLCong Liu
Cong Liu
QLQi Li
Qi Li
YMYinghao Meng
Yinghao Meng
FLFang Liu
Fang Liu
JLJianping Lu
Jianping Lu

8 November 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
YMYinghao Meng
Yinghao Meng
HZHao Zhang
Hao Zhang
QLQi Li
Qi Li
FLFang Liu
Fang Liu
XFXu Fang
Xu Fang
CSChengwei Shao
Chengwei Shao
Purpose: To develop and validate a machine learning classifier based on multidetector computed tomography (MDCT), for the preoperative prediction of tumor–stroma ratio (TSR) expression in patients with pancreatic ductal adenocarcinoma (PDAC). Materials and Methods: In this retrospective study, 227 patients with PDAC underwent an MDCT scan and surgical resection. We quantified the TSR by using hematoxylin and eosin staining and extracted 1409 arterial and portal venous phase radiomics features for each patient, respectively. Moreover, we used the least absolute shrinkage and selection operator logistic regression algorithm to reduce the features. The extreme gradient boosting (XGBoost) was developed using a training set consisting of 167 consecutive patients, admitted between December 2016 and December 2017. The model was validated in 60 consecutive patients, admitted between January 2018 and April 2018. We determined the XGBoost classifier performance based on its discriminative ability, calibration, and clinical utility. Results: We observed low and high TSR in 91 (40.09%) and 136 (59.91%) patients, respectively. A log-rank test revealed significantly longer survival for patients in the TSR-low group than those in the TSR-high group. The prediction model revealed good discrimination in the training (area under the curve [AUC]= 0.93) and moderate discrimination in the validation set (AUC= 0.63). While the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for the training set were 94.06%, 81.82%, 0.89, 0.89, and 0.90, respectively, those for the validation set were 85.71%, 48.00%, 0.70, 0.70, and 0.71, respectively. Conclusions: The CT radiomics-based XGBoost classifier provides a potentially valuable noninvasive tool to predict TSR in patients with PDAC and optimize risk stratification.

1 April 2022 in Academic Radiology
Verified
Journal Article
Closed access
CLCong Liu
Cong Liu
YBYun Bian
Yun Bian
YMYinghao Meng
Yinghao Meng
FLFang Liu
Fang Liu
KCKai Cao
Kai Cao
CSChengwei Shao
Chengwei Shao

13 October 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
XYXiaohan Yuan
Xiaohan Yuan
CCChengwei Chen
Chengwei Chen
ZSZhang Shi
Zhang Shi
WLWenbin Liu
Wenbin Liu
XZXinyue Zhang
Xinyue Zhang
YBYun Bian
Yun Bian
Pancreatic cystic neoplasms (PCN) are critical precursors for early pancreatic cancer detection, yet current diagnostic methods lack accuracy and consistency. This multicenter study developed and validated an artificial intelligence (AI)-powered CT model (PCN-AI) for improved assessment. Using contrast-enhanced CT images from 1835 patients, PCN-AI extracted 63 quantitative features to classify PCN subtypes through four hierarchical tasks. A multi-reader, multi-case (MRMC) study demonstrated that AI assistance significantly improved radiologists’ diagnostic accuracy (AUC: 0.786 to 0.845; p < 0.05) and reduced interpretation time by 23.7% (5.28 vs. 4.03 minutes/case). Radiologists accepted AI recommendations in 87.14% of cases. In a prospective real-world cohort, PCN-AI outperformed radiologist double-reading, providing actionable diagnostic benefits to 45.45% of patients (5/11) by correctly identifying missed malignant PCN cases, enabling timely intervention, and simultaneously reducing clinical workload by 39.3%. PCN-AI achieved robust performance across tasks (AUCs: 0.845–0.988), demonstrating its potential to enhance early detection, precision management, and diagnostic efficiency in clinical practice.